凤凰网首页 手机凤凰网

凤凰卫视
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
免费注册
泰合健康(000790)公告正文

泰合健康:2019年第一季度报告全文

公告日期 2019-04-27
股票简称:泰合健康 股票代码:000790
               成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文




成都泰合健康科技集团股份有限公司

       2019 年第一季度报告

             2019-013




          2019 年 04 月




                                                                     1
                                 成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文




                         第一节 重要提示


    公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真

实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和

连带的法律责任。

    所有董事均已出席了审议本次季报的董事会会议。

    公司负责人李小平、主管会计工作负责人王晓梅及会计机构负责人(会计主

管人员)郭婷声明:保证季度报告中财务报表的真实、准确、完整。




                                                                                       2
                                                         成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文




                                      第二节 公司基本情况

一、主要会计数据和财务指标

公司是否需追溯调整或重述以前年度会计数据
√ 是 □ 否
追溯调整或重述原因
会计政策变更

                                                                                                       本报告期比上年同
                                                                             上年同期
                                             本报告期                                                         期增减

                                                                    调整前              调整后                调整后

营业收入(元)                                  156,742,829.38    130,912,247.37   130,912,247.37                  19.73%

归属于上市公司股东的净利润(元)                 12,302,591.47      5,286,093.77        5,286,093.77              132.74%

归属于上市公司股东的扣除非经常性损
                                                 12,220,691.95      3,682,574.11        3,682,574.11              231.85%
益的净利润(元)

经营活动产生的现金流量净额(元)                  5,374,968.56    -30,174,246.59    -30,174,246.59                117.81%

基本每股收益(元/股)                                    0.0220          0.0094              0.0094               134.04%

稀释每股收益(元/股)                                    0.0220          0.0094              0.0094               134.04%

加权平均净资产收益率                                     1.46%            0.98%               0.98%                    0.48%

                                                                                                       本报告期末比上年
                                                                             上年度末
                                            本报告期末                                                     度末增减

                                                                    调整前              调整后                调整后

总资产(元)                                  1,098,404,605.42 1,084,104,689.47 1,084,104,689.47                       1.32%

归属于上市公司股东的净资产(元)                847,853,684.41    835,551,092.94   835,551,092.94                      1.47%

会计政策变更的原因及会计差错更正的情况
财政部于 2018 年 6 月 15 日发布了《财政部关于修订印发 2018 年度一般企业财务报表格式的通知》(财会[2018]15 号,以下
简称“新修订的财务报表格式”)。新修订的财务报表格式主要将资产负债表中的部分项目合并列报,在利润表中将原“管理费
用”中的研发费用分拆单独列示,新增“研发费用”项目,反映企业进行研究与开发过程中发生的费用化支出。本公司按照《企
业会计准则第 30 号——财务报表列报》等相关规定,对此项会计政策变更采用追溯调整法, 2018 年一季度财务报表已重
新表述。该变更对本集团财务状况、经营成果和现金流量无重大影响。
非经常性损益项目和金额
√ 适用 □ 不适用
                                                                                                                  单位:元

                          项目                               年初至报告期期末金额                      说明

非流动资产处置损益(包括已计提资产减值准备的冲销部分)                         -522.63

计入当期损益的政府补助(与企业业务密切相关,按照国家统                       96,875.01



                                                                                                                               3
                                                         成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


一标准定额或定量享受的政府补助除外)

减:所得税影响额                                                              14,452.86

合计                                                                          81,899.52              --

对公司根据《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》定义界定的非经常性损益项目,以及把《公
开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》中列举的非经常性损益项目界定为经常性损益的项目,应
说明原因
□ 适用 √ 不适用
公司报告期不存在将根据《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》定义、列举的非经常性损益
项目界定为经常性损益的项目的情形。


二、报告期末股东总数及前十名股东持股情况表

1、普通股股东总数和表决权恢复的优先股股东数量及前 10 名股东持股情况表

                                                                                                               单位:股

                                                   报告期末表决权恢复的优先股股
报告期末普通股股东总数                    44,536                                                                     0
                                                   东总数(如有)

                                                 前 10 名股东持股情况

                                                                      持有有限售条件          质押或冻结情况
   股东名称            股东性质      持股比例         持股数量
                                                                        的股份数量        股份状态          数量

四川华神集团股
                    境内非国有法人        18.08%        101,301,165
份有限公司

王安全              境内自然人             5.00%         28,016,466

丁书干              境内自然人             1.39%          7,800,000

赵顺斌              境内自然人             1.34%          7,483,600

林洁君              境内自然人             0.96%          5,396,500

黄益中              境内自然人             0.79%          4,449,099

河南融通投资有
                    境内非国有法人         0.75%          4,218,800
限公司

余浩鑫              境内自然人             0.62%          3,501,200

陈方方              境内自然人             0.59%          3,317,810

赵玉涛              境内自然人             0.40%          2,237,750

                                         前 10 名无限售条件股东持股情况

                                                                                                 股份种类
             股东名称                           持有无限售条件股份数量
                                                                                          股份种类          数量

四川华神集团股份有限公司                                                  101,301,165 人民币普通股          101,301,165

王安全                                                                     28,016,466 人民币普通股           28,016,466



                                                                                                                          4
                                                      成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


丁书干                                                                7,800,000 人民币普通股        7,800,000

赵顺斌                                                                7,483,600 人民币普通股        7,483,600

林洁君                                                                5,396,500 人民币普通股        5,396,500

黄益中                                                                4,449,099 人民币普通股        4,449,099

河南融通投资有限公司                                                  4,218,800 人民币普通股        4,218,800

余浩鑫                                                                3,501,200 人民币普通股        3,501,200

陈方方                                                                3,317,810 人民币普通股        3,317,810

赵玉涛                                                                2,237,750 人民币普通股        2,237,750

                                 王安全系公司实际控制人、董事长王仁果的父亲,与公司控股股东四川华神集团股份有
上述股东关联关系或一致行动的
                                 限公司构成一致行动人。上述其余股东之间,公司未知其是否属于《上市公司收购管理
说明
                                 办法》规定的一致行动人。

                                 王安全通过信用交易担保证券账户持有公司股票 28016466 股。
                                 丁书干通过信用交易担保证券账户持有公司股票 7800000 股。
                                 赵顺斌通过信用交易担保证券账户持有公司股票 6483600 股。
前 10 名普通股股东参与融资融券
                                 林洁君通过信用交易担保证券账户持有公司股票 5390000 股。
业务情况说明(如有)
                                 河南融通投资有限公司通过信用交易担保证券账户持有公司股票 4218800 股。
                                 余浩鑫通过信用交易担保证券账户持有公司股票 3500000 股。
                                 赵玉涛通过信用交易担保证券账户持有公司股票 2237750 股。

公司前 10 名普通股股东、前 10 名无限售条件普通股股东在报告期内是否进行约定购回交易
□ 是 √ 否
公司前 10 名普通股股东、前 10 名无限售条件普通股股东在报告期内未进行约定购回交易。


2、公司优先股股东总数及前 10 名优先股股东持股情况表

□ 适用 √ 不适用




                                                                                                                5
                                                      成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文




                                         第三节 重要事项

一、报告期主要财务数据、财务指标发生变动的情况及原因

√ 适用 □ 不适用
1、应收票据本报告期末较期初增加 2,824.41万元,增长 63.96%,主要系本报告期中西成药产业票据回款增加所致;
2、预付款项本报告期末较期初增加 403.80万元,增长 44.55%,主要系本报告期钢结构产业预付工程材料款增加所致;
3、经营活动产生的现金流量净额本报告期较上年同期增加 3,554.92万元,主要系本期销售规模增加使得销售商品提供劳务
收到的现金同比增加 1,536.40万元,同时本期购买商品、接受劳务支付的现金同比减少1,721.60万元;
4、投资活动产生的现金流量净额本报告期较上年同期减少 7,638.95万元,主要系上年同期收到四川温资股权转让款及延期
付款补偿金合计 8,179.28万元,本报告期无此业务;
5、筹资活动产生的现金流量净额本报告期较上年同期减少 1,061.77万元,主要系上年同期收回前期缴纳的流动资金借款保
证金,使本报告期收到其他与筹资活动有关的现金同比减少 1,264.07万元。


二、重要事项进展情况及其影响和解决方案的分析说明

√ 适用 □ 不适用
1、2019年4月10日,公司2018年年度股东大会审议通过2018年度利润分配预案:以截止2018年12月31日的公司总股本
560,327,786为基数,向全体股东每10股派发现金红利0.30元(含税),送红股1股(含税),不以公积金转增股本。
2、2018年3月27日,公司2017年年度股东大会审议通过《关于钢构公司向PPP项目公司增加投资的议案》,同意钢构公司对
南充十七冶江东标美建设投资管理有限公司增加投资项目资本金8009.754万元,占拟增加投资项目资本金总额的85%。截至
本报告期末,钢构公司已增加投资项目资本金2002.99万元。

             重要事项概述                          披露日期                    临时报告披露网站查询索引

                                                                         http://www.cninfo.com.cn/new/disclosure/
                                                                         detail?plate=&orgId=gssz0000790&stock
重大资产重组                        2019 年 03 月 28 日
                                                                         Code=000790&announcementId=1205948
                                                                         139&announcementTime=2019-03-28

股份回购的实施进展情况
□ 适用 √ 不适用
采用集中竞价方式减持回购股份的实施进展情况
□ 适用 √ 不适用


三、公司实际控制人、股东、关联方、收购人以及公司等承诺相关方在报告期内超期未履行
完毕的承诺事项

□ 适用 √ 不适用
公司报告期不存在公司实际控制人、股东、关联方、收购人以及公司等承诺相关方在报告期内超期未履行完毕的承诺事项。


四、对 2019 年 1-6 月经营业绩的预计

预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生大幅度变动的警示及原因说明

                                                                                                                    6
                                                    成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


□ 适用 √ 不适用


五、证券投资情况

□ 适用 √ 不适用
公司报告期不存在证券投资。


六、衍生品投资情况

□ 适用 √ 不适用
公司报告期不存在衍生品投资。


七、报告期内接待调研、沟通、采访等活动登记表

√ 适用 □ 不适用

        接待时间                 接待方式              接待对象类型             调研的基本情况索引

                                                                         报告期内回复投资者互动易问询十几
2019 年 03 月 31 日     书面问询                个人
                                                                         条,多为投资者问询生产经营等情况。

                                                                         报告期内接听投资者电话数十次,多为
2019 年 03 月 31 日     电话沟通                个人
                                                                         投资者问询生产经营等情况。


八、违规对外担保情况

□ 适用 √ 不适用
公司报告期无违规对外担保情况。


九、控股股东及其关联方对上市公司的非经营性占用资金情况

□ 适用 √ 不适用
公司报告期不存在控股股东及其关联方对上市公司的非经营性占用资金。




                                                                                                              7
                                                    成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文




                                        第四节 财务报表

一、财务报表

1、合并资产负债表

编制单位:成都泰合健康科技集团股份有限公司
                                             2019 年 03 月 31 日
                                                                                                      单位:元

                  项目                       2019 年 3 月 31 日                 2018 年 12 月 31 日

流动资产:

    货币资金                                               352,875,780.89                      346,085,862.03

    结算备付金

    拆出资金

    交易性金融资产

    以公允价值计量且其变动计入当期
损益的金融资产

    衍生金融资产

    应收票据及应收账款                                     353,480,620.34                      346,127,666.85

      其中:应收票据                                        72,404,188.88                       44,160,104.88

               应收账款                                    281,076,431.46                      301,967,561.97

    预付款项                                                13,101,418.54                        9,063,373.23

    应收保费

    应收分保账款

    应收分保合同准备金

    其他应收款                                                7,318,957.88                       5,285,720.94

      其中:应收利息

               应收股利

    买入返售金融资产

    存货                                                    78,427,289.04                       80,182,649.32

    合同资产

    持有待售资产

    一年内到期的非流动资产

    其他流动资产



                                                                                                                8
                                     成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


流动资产合计                               805,204,066.69                      786,745,272.37

非流动资产:

    发放贷款和垫款

    债权投资

    可供出售金融资产                                                              100,000.00

    其他债权投资

    持有至到期投资

    长期应收款

    长期股权投资                             4,579,613.01                        5,164,551.50

    其他权益工具投资                          100,000.00

    其他非流动金融资产

    投资性房地产                            34,900,692.24                       35,222,216.73

    固定资产                               184,123,290.34                      186,940,245.57

    在建工程                                                                        26,000.00

    生产性生物资产

    油气资产

    使用权资产

    无形资产                                18,523,710.90                       18,904,813.14

    开发支出

    商誉

    长期待摊费用                              652,228.20                          680,586.12

    递延所得税资产                           4,791,070.74                        4,791,070.74

    其他非流动资产                          45,529,933.30                       45,529,933.30

非流动资产合计                             293,200,538.73                      297,359,417.10

资产总计                                 1,098,404,605.42                    1,084,104,689.47

流动负债:

    短期借款

    向中央银行借款

    拆入资金

    交易性金融负债

    以公允价值计量且其变动计入当期
损益的金融负债

    衍生金融负债

    应付票据及应付账款                     135,062,973.12                      127,230,209.72




                                                                                                9
                             成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


    预收款项                         9,843,828.20                       12,177,206.85

    卖出回购金融资产款

    吸收存款及同业存放

    代理买卖证券款

    代理承销证券款

    应付职工薪酬                    10,206,956.84                       11,887,230.63

    应交税费                        55,742,779.67                       61,865,539.27

    其他应付款                      25,837,549.35                       21,439,701.22

      其中:应付利息

               应付股利                  1,160.44                            1,160.44

    应付手续费及佣金

    应付分保账款

    合同负债

    持有待售负债

    一年内到期的非流动负债

    其他流动负债                      387,500.04                          387,500.04

流动负债合计                       237,081,587.22                      234,987,387.73

非流动负债:

    保险合同准备金

    长期借款

    应付债券

      其中:优先股

               永续债

    租赁负债

    长期应付款                      11,400,000.00                       11,400,000.00

    长期应付职工薪酬

    预计负债

    递延收益                         2,066,666.48                        2,163,541.49

    递延所得税负债                       2,667.31                            2,667.31

    其他非流动负债

非流动负债合计                      13,469,333.79                       13,566,208.80

负债合计                           250,550,921.01                      248,553,596.53

所有者权益:

    股本                           560,327,786.00                      560,327,786.00



                                                                                   10
                                                  成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


    其他权益工具

      其中:优先股

               永续债

    资本公积                                              39,580,621.10                       39,580,621.10

    减:库存股

    其他综合收益

    专项储备

    盈余公积                                             106,045,817.60                      106,045,817.60

    一般风险准备

    未分配利润                                           141,899,459.71                      129,596,868.24

归属于母公司所有者权益合计                               847,853,684.41                      835,551,092.94

    少数股东权益

所有者权益合计                                           847,853,684.41                      835,551,092.94

负债和所有者权益总计                                   1,098,404,605.42                    1,084,104,689.47


法定代表人:李小平                   主管会计工作负责人:王晓梅                     会计机构负责人:郭婷


2、母公司资产负债表

                                                                                                    单位:元

                  项目                     2019 年 3 月 31 日                 2018 年 12 月 31 日

流动资产:

    货币资金                                             298,643,027.31                      315,126,829.30

    交易性金融资产

    以公允价值计量且其变动计入当期
损益的金融资产

    衍生金融资产

    应收票据及应收账款                                   143,512,699.01                      115,430,088.72

      其中:应收票据                                      12,497,046.06                        5,801,055.88

               应收账款                                  131,015,652.95                      109,629,032.84

    预付款项                                                8,385,678.89                       6,366,383.12

    其他应收款                                           209,654,828.72                      194,700,801.47

      其中:应收利息

               应收股利

    存货                                                  58,572,657.83                       55,338,061.45

    合同资产


                                                                                                          11
                                     成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


    持有待售资产

    一年内到期的非流动资产

    其他流动资产                                                                  170,390.78

流动资产合计                               718,768,891.76                      687,132,554.84

非流动资产:

    债权投资

    可供出售金融资产                                                              100,000.00

    其他债权投资

    持有至到期投资

    长期应收款

    长期股权投资                           165,490,000.00                      165,490,000.00

    其他权益工具投资                          100,000.00

    其他非流动金融资产

    投资性房地产

    固定资产                               163,643,381.28                      165,672,123.21

    在建工程

    生产性生物资产

    油气资产

    使用权资产

    无形资产                                10,957,511.58                       11,072,175.81

    开发支出

    商誉

    长期待摊费用

    递延所得税资产                           3,040,820.53                        3,040,820.53

    其他非流动资产

非流动资产合计                             343,231,713.39                      345,375,119.55

资产总计                                 1,062,000,605.15                    1,032,507,674.39

流动负债:

    短期借款

    交易性金融负债

    以公允价值计量且其变动计入当期
损益的金融负债

    衍生金融负债

    应付票据及应付账款                      80,256,944.95                       72,079,366.11




                                                                                           12
                             成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


    预收款项                         1,263,757.96                        1,727,309.66

    合同负债

    应付职工薪酬                     2,117,250.88                        3,069,828.96

    应交税费                        47,180,819.03                       51,509,897.91

    其他应付款                      13,110,766.47                       12,575,993.47

      其中:应付利息

               应付股利

    持有待售负债

    一年内到期的非流动负债

    其他流动负债                      387,500.04                          387,500.04

流动负债合计                       144,317,039.33                      141,349,896.15

非流动负债:

    长期借款

    应付债券

      其中:优先股

               永续债

    租赁负债

    长期应付款                       3,700,000.00                        3,700,000.00

    长期应付职工薪酬

    预计负债

    递延收益                         2,066,666.48                        2,163,541.49

    递延所得税负债                       2,667.31                            2,667.31

    其他非流动负债

非流动负债合计                       5,769,333.79                        5,866,208.80

负债合计                           150,086,373.12                      147,216,104.95

所有者权益:

    股本                           560,327,786.00                      560,327,786.00

    其他权益工具

      其中:优先股

               永续债

    资本公积                        71,028,790.27                       71,028,790.27

    减:库存股

    其他综合收益

    专项储备



                                                                                   13
                                           成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


    盈余公积                                     106,045,817.60                      106,045,817.60

    未分配利润                                   174,511,838.16                      147,889,175.57

所有者权益合计                                   911,914,232.03                      885,291,569.44

负债和所有者权益总计                           1,062,000,605.15                    1,032,507,674.39


3、合并利润表

                                                                                             单位:元

                    项目                   本期发生额                       上期发生额

一、营业总收入                                     156,742,829.38                    130,912,247.37

    其中:营业收入                                 156,742,829.38                    130,912,247.37

          利息收入

          已赚保费

          手续费及佣金收入

二、营业总成本                                     139,162,182.83                    121,700,557.34

    其中:营业成本                                  47,277,854.54                     46,535,669.90

          利息支出

          手续费及佣金支出

          退保金

          赔付支出净额

          提取保险合同准备金净额

          保单红利支出

          分保费用

          税金及附加                                    3,169,970.17                     1,607,555.74

          销售费用                                  74,952,330.94                     59,952,796.50

          管理费用                                  11,769,300.90                        9,974,646.61

          研发费用                                      3,547,484.93                     3,598,557.46

          财务费用                                      -1,554,758.65                      31,331.13

               其中:利息费用                                                            2,023,025.00

                     利息收入                           1,561,135.70                     2,018,202.27

          资产减值损失

          信用减值损失

    加:其他收益                                           96,875.01                       96,875.01

        投资收益(损失以“-”号填列)                   -584,938.49                     -127,455.46

        其中:对联营企业和合营企业的投资                 -584,938.49                     -127,455.46



                                                                                                   14
                                                成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


收益

         汇兑收益(损失以“-”号填列)

         净敞口套期收益(损失以“-”号填
列)

         公允价值变动收益(损失以“-”号填
列)

         资产处置收益(损失以“-”号填列)                                                       -575.00

三、营业利润(亏损以“-”号填列)                       17,092,583.07                      9,180,534.58

     加:营业外收入                                            600.00                       1,792,800.00

     减:营业外支出                                           1,122.63                          3,181.29

四、利润总额(亏损总额以“-”号填列)                   17,092,060.44                     10,970,153.29

     减:所得税费用                                       4,789,468.97                      5,684,059.52

五、净利润(净亏损以“-”号填列)                       12,302,591.47                      5,286,093.77

  (一)按经营持续性分类

     1.持续经营净利润(净亏损以“-”号填列)            12,302,591.47                      5,286,093.77

     2.终止经营净利润(净亏损以“-”号填列)

  (二)按所有权属分类

     1.归属于母公司所有者的净利润                        12,302,591.47                      5,286,093.77

     2.少数股东损益

六、其他综合收益的税后净额

  归属母公司所有者的其他综合收益的税后
净额

     (一)不能重分类进损益的其他综合收益

           1.重新计量设定受益计划变动额

           2.权益法下不能转损益的其他综合
收益

           3.其他权益工具投资公允价值变动

           4.企业自身信用风险公允价值变动

           5.其他

     (二)将重分类进损益的其他综合收益

           1.权益法下可转损益的其他综合收


           2.其他债权投资公允价值变动

           3.可供出售金融资产公允价值变动
损益

           4.金融资产重分类计入其他综合收


                                                                                                      15
                                                       成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


益的金额

             5.持有至到期投资重分类为可供出
售金融资产损益

             6.其他债权投资信用减值准备

             7.现金流量套期储备

             8.外币财务报表折算差额

             9.其他

  归属于少数股东的其他综合收益的税后净


七、综合收益总额                                                   12,302,591.47                    5,286,093.77

     归属于母公司所有者的综合收益总额                              12,302,591.47                    5,286,093.77

     归属于少数股东的综合收益总额

八、每股收益:

     (一)基本每股收益                                                  0.0220                          0.0094

     (二)稀释每股收益                                                  0.0220                          0.0094

本期发生同一控制下企业合并的,被合并方在合并前实现的净利润为:元,上期被合并方实现的净利润为:元。


法定代表人:李小平                        主管会计工作负责人:王晓梅                     会计机构负责人:郭婷


4、母公司利润表

                                                                                                        单位:元

                 项目                            本期发生额                           上期发生额

一、营业收入                                                  101,562,263.53                       88,051,264.46

     减:营业成本                                              37,850,999.95                       39,055,974.65

           税金及附加                                           1,967,479.10                        1,157,733.05

           销售费用                                            25,772,822.08                        5,108,475.88

           管理费用                                             5,405,482.10                        5,708,276.84

           研发费用                                              787,967.86                          657,825.58

           财务费用                                            -1,538,266.74                         253,687.77

               其中:利息费用                                                                       2,023,025.00

                      利息收入                                  1,542,469.79                        1,779,343.35

           资产减值损失

           信用减值损失

     加:其他收益                                                  96,875.01                          96,875.01

           投资收益(损失以“-”号填



                                                                                                              16
                                         成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


列)

           其中:对联营企业和合营企
业的投资收益

           净敞口套期收益(损失以
“-”号填列)

           公允价值变动收益(损失以
“-”号填列)

           资产处置收益(损失以“-”号
                                                                                          -575.00
填列)

二、营业利润(亏损以“-”号填列)            31,412,654.19                         36,205,590.70

    加:营业外收入                                  600.00                           1,792,800.00

    减:营业外支出                                 1,122.63                              3,181.29

三、利润总额(亏损总额以“-”号填
                                              31,412,131.56                         37,995,209.41
列)

    减:所得税费用                             4,789,468.97                          5,684,059.52

四、净利润(净亏损以“-”号填列)            26,622,662.59                         32,311,149.89

    (一)持续经营净利润(净亏损
                                              26,622,662.59                         32,311,149.89
以“-”号填列)

    (二)终止经营净利润(净亏损
以“-”号填列)

五、其他综合收益的税后净额

    (一)不能重分类进损益的其他
综合收益

             1.重新计量设定受益计划
变动额

             2.权益法下不能转损益的
其他综合收益

             3.其他权益工具投资公允
价值变动

             4.企业自身信用风险公允
价值变动

             5.其他

    (二)将重分类进损益的其他综
合收益

             1.权益法下可转损益的其
他综合收益

             2.其他债权投资公允价值
变动


                                                                                               17
                                          成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


           3.可供出售金融资产公允
价值变动损益

           4.金融资产重分类计入其
他综合收益的金额

           5.持有至到期投资重分类
为可供出售金融资产损益

           6.其他债权投资信用减值
准备

           7.现金流量套期储备

           8.外币财务报表折算差额

           9.其他

六、综合收益总额                                   26,622,662.59                      32,311,149.89

七、每股收益:

     (一)基本每股收益

     (二)稀释每股收益


5、合并现金流量表

                                                                                           单位:元

               项目                 本期发生额                          上期发生额

一、经营活动产生的现金流量:

     销售商品、提供劳务收到的现金                156,209,653.11                      140,845,684.22

     客户存款和同业存放款项净增
加额

     向中央银行借款净增加额

     向其他金融机构拆入资金净增
加额

     收到原保险合同保费取得的现


     收到再保险业务现金净额

     保户储金及投资款净增加额

     处置以公允价值计量且其变动
计入当期损益的金融资产净增加额

     收取利息、手续费及佣金的现金

     拆入资金净增加额

     回购业务资金净增加额

     代理买卖证券收到的现金净额


                                                                                                 18
                                    成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


     收到的税费返还

     收到其他与经营活动有关的现
                                         2,384,970.92                           1,848,364.85


经营活动现金流入小计                   158,594,624.03                         142,694,049.07

     购买商品、接受劳务支付的现金       34,741,400.87                          51,957,376.47

     客户贷款及垫款净增加额

     存放中央银行和同业款项净增
加额

     支付原保险合同赔付款项的现


     为交易目的而持有的金融资产
净增加额

     拆出资金净增加额

     支付利息、手续费及佣金的现金

     支付保单红利的现金

     支付给职工以及为职工支付的
                                        18,129,770.90                          18,789,718.37
现金

     支付的各项税费                     30,840,258.84                          36,089,123.89

     支付其他与经营活动有关的现
                                        69,508,224.86                          66,032,076.93


经营活动现金流出小计                   153,219,655.47                         172,868,295.66

经营活动产生的现金流量净额               5,374,968.56                         -30,174,246.59

二、投资活动产生的现金流量:

     收回投资收到的现金

     取得投资收益收到的现金

     处置固定资产、无形资产和其他
                                                                               81,792,800.00
长期资产收回的现金净额

     处置子公司及其他营业单位收
到的现金净额

     收到其他与投资活动有关的现
                                         1,548,013.30                           1,785,441.41


投资活动现金流入小计                     1,548,013.30                          83,578,241.41

     购建固定资产、无形资产和其他
                                           133,063.00                           5,773,744.51
长期资产支付的现金

     投资支付的现金

     质押贷款净增加额




                                                                                          19
                                          成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


     取得子公司及其他营业单位支
付的现金净额

     支付其他与投资活动有关的现


投资活动现金流出小计                                133,063.00                         5,773,744.51

投资活动产生的现金流量净额                         1,414,950.30                       77,804,496.90

三、筹资活动产生的现金流量:

     吸收投资收到的现金

     其中:子公司吸收少数股东投资
收到的现金

     取得借款收到的现金

     发行债券收到的现金

     收到其他与筹资活动有关的现
                                                                                      12,640,741.39


筹资活动现金流入小计                                                                  12,640,741.39

     偿还债务支付的现金

     分配股利、利润或偿付利息支付
                                                                                       2,023,024.99
的现金

     其中:子公司支付给少数股东的
股利、利润

     支付其他与筹资活动有关的现


筹资活动现金流出小计                                                                   2,023,024.99

筹资活动产生的现金流量净额                                                            10,617,716.40

四、汇率变动对现金及现金等价物的
影响

五、现金及现金等价物净增加额                       6,789,918.86                       58,247,966.71

     加:期初现金及现金等价物余额                346,085,862.03                      430,375,865.10

六、期末现金及现金等价物余额                     352,875,780.89                      488,623,831.81


6、母公司现金流量表

                                                                                           单位:元

               项目                 本期发生额                          上期发生额

一、经营活动产生的现金流量:

     销售商品、提供劳务收到的现金                 76,082,618.49                       54,257,675.63

     收到的税费返还


                                                                                                 20
                                    成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


     收到其他与经营活动有关的现
                                                                                    9,000.00


经营活动现金流入小计                    76,082,618.49                          54,266,675.63

     购买商品、接受劳务支付的现金       29,810,651.98                          40,659,630.96

     支付给职工以及为职工支付的
                                         7,935,382.19                           8,646,189.12
现金

     支付的各项税费                     20,897,487.25                          20,305,146.33

     支付其他与经营活动有关的现
                                        20,333,892.59                           8,382,678.32


经营活动现金流出小计                    78,977,414.01                          77,993,644.73

经营活动产生的现金流量净额               -2,894,795.52                        -23,726,969.10

二、投资活动产生的现金流量:

     收回投资收到的现金

     取得投资收益收到的现金

     处置固定资产、无形资产和其他
                                                                               81,792,800.00
长期资产收回的现金净额

     处置子公司及其他营业单位收
到的现金净额

     收到其他与投资活动有关的现
                                         1,544,056.53                           1,779,341.41


投资活动现金流入小计                     1,544,056.53                          83,572,141.41

     购建固定资产、无形资产和其他
                                           133,063.00                           5,773,744.51
长期资产支付的现金

     投资支付的现金

     取得子公司及其他营业单位支
付的现金净额

     支付其他与投资活动有关的现
                                        15,000,000.00                          10,097,540.00


投资活动现金流出小计                    15,133,063.00                          15,871,284.51

投资活动产生的现金流量净额              -13,589,006.47                         67,700,856.90

三、筹资活动产生的现金流量:

     吸收投资收到的现金

     取得借款收到的现金

     发行债券收到的现金

     收到其他与筹资活动有关的现
                                                                               97,640,741.39





                                                                                          21
                                                           成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


筹资活动现金流入小计                                                                                  97,640,741.39

     偿还债务支付的现金

     分配股利、利润或偿付利息支付
                                                                                                       2,023,024.99
的现金

     支付其他与筹资活动有关的现


筹资活动现金流出小计                                                                                   2,023,024.99

筹资活动产生的现金流量净额                                                                            95,617,716.40

四、汇率变动对现金及现金等价物的
影响

五、现金及现金等价物净增加额                                   -16,483,801.99                        139,591,604.20

     加:期初现金及现金等价物余额                             315,126,829.30                         269,567,131.71

六、期末现金及现金等价物余额                                  298,643,027.31                         409,158,735.91


二、财务报表调整情况说明

1、首次执行新金融工具准则、新收入准则、新租赁准则调整首次执行当年年初财务报表相关情况

√ 适用 □ 不适用
合并资产负债表
                                                                                                             单位:元

            项目               2018 年 12 月 31 日               2019 年 1 月 1 日               调整数

流动资产:

     货币资金                            346,085,862.03                   346,085,862.03

     应收票据及应收账款                  346,127,666.85                   346,127,666.85

         其中:应收票据                   44,160,104.88                    44,160,104.88

                应收账款                 301,967,561.97                   301,967,561.97

     预付款项                              9,063,373.23                     9,063,373.23

     其他应收款                            5,285,720.94                     5,285,720.94

     存货                                 80,182,649.32                    80,182,649.32

流动资产合计                             786,745,272.37                   786,745,272.37

非流动资产:

     可供出售金融资产                         100,000.00              不适用                              -100,000.00

     长期股权投资                          5,164,551.50                     5,164,551.50

     其他权益工具投资                不适用                                     100,000.00                100,000.00

     投资性房地产                         35,222,216.73                    35,222,216.73




                                                                                                                   22
                                                        成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


    固定资产                           186,940,245.57                 186,940,245.57

    在建工程                                26,000.00                      26,000.00

    无形资产                            18,904,813.14                  18,904,813.14

    长期待摊费用                          680,586.12                     680,586.12

    递延所得税资产                       4,791,070.74                   4,791,070.74

    其他非流动资产                      45,529,933.30                  45,529,933.30

非流动资产合计                         297,359,417.10                 297,359,417.10

资产总计                             1,084,104,689.47               1,084,104,689.47

流动负债:

    应付票据及应付账款                 127,230,209.72                 127,230,209.72

    预收款项                            12,177,206.85                  12,177,206.85

    应付职工薪酬                        11,887,230.63                  11,887,230.63

    应交税费                            61,865,539.27                  61,865,539.27

    其他应付款                          21,439,701.22                  21,439,701.22

               应付股利                      1,160.44                       1,160.44

    其他流动负债                          387,500.04                     387,500.04

流动负债合计                           234,987,387.73                 234,987,387.73

非流动负债:

    长期应付款                          11,400,000.00                  11,400,000.00

    递延收益                             2,163,541.49                   2,163,541.49

    递延所得税负债                           2,667.31                       2,667.31

非流动负债合计                          13,566,208.80                  13,566,208.80

负债合计                               248,553,596.53                 248,553,596.53

所有者权益:

    股本                               560,327,786.00                 560,327,786.00

    资本公积                            39,580,621.10                  39,580,621.10

    盈余公积                           106,045,817.60                 106,045,817.60

    未分配利润                         129,596,868.24                 129,596,868.24

归属于母公司所有者权益
                                       835,551,092.94                 835,551,092.94
合计

所有者权益合计                         835,551,092.94                 835,551,092.94

负债和所有者权益总计                 1,084,104,689.47               1,084,104,689.47

调整情况说明
   2017年3月31日,财政部修订了《企业会计准则第22号—金融工具确认和计量》、《企业会计准则第23号—金融资产转
移》、《企业会计准则第24号—套期会计》及《企业会计准则第37号—金融工具列报》,并要求境内上市公司自2019年1月1


                                                                                                             23
                                                          成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


日起施行。准则规定,在准则实施日,企业应当按照规定对金融工具进行分类和计量,涉及前期比较财务报表数据与本准则
要求不一致的,无需调整。金融工具原账面价值和在本准则实施日的新账面价值之间的差额,需要调整2019年初留存收益、
其他综合收益及财务报表其他项目金额。本公司于2019年1月1日之后将部分持有的股权投资指定为以公允价值计量且其变动
计入其他综合收益的金融资产,列报为其他权益工具投资。
母公司资产负债表
                                                                                                            单位:元

           项目               2018 年 12 月 31 日               2019 年 1 月 1 日               调整数

流动资产:

    货币资金                            315,126,829.30                   315,126,829.30

    应收票据及应收账款                  115,430,088.72                   115,430,088.72

      其中:应收票据                      5,801,055.88                     5,801,055.88

               应收账款                 109,629,032.84                   109,629,032.84

    预付款项                              6,366,383.12                     6,366,383.12

    其他应收款                          194,700,801.47                   194,700,801.47

    存货                                 55,338,061.45                    55,338,061.45

    其他流动资产                             170,390.78                      170,390.78

流动资产合计                            687,132,554.84                   687,132,554.84

非流动资产:

    可供出售金融资产                         100,000.00             不适用                               -100,000.00

    长期股权投资                        165,490,000.00                   165,490,000.00

    其他权益工具投资                不适用                                   100,000.00                  100,000.00

    固定资产                            165,672,123.21                   165,672,123.21

    无形资产                             11,072,175.81                    11,072,175.81

    递延所得税资产                        3,040,820.53                     3,040,820.53

非流动资产合计                          345,375,119.55                   345,375,119.55

资产总计                              1,032,507,674.39                 1,032,507,674.39

流动负债:

    应付票据及应付账款                   72,079,366.11                    72,079,366.11

    预收款项                              1,727,309.66                     1,727,309.66

    应付职工薪酬                          3,069,828.96                     3,069,828.96

    应交税费                             51,509,897.91                    51,509,897.91

    其他应付款                           12,575,993.47                    12,575,993.47

    其他流动负债                             387,500.04                      387,500.04

流动负债合计                            141,349,896.15                   141,349,896.15

非流动负债:



                                                                                                                  24
                                                        成都泰合健康科技集团股份有限公司 2019 年第一季度报告全文


     长期应付款                          3,700,000.00                   3,700,000.00

     递延收益                            2,163,541.49                   2,163,541.49

     递延所得税负债                          2,667.31                       2,667.31

非流动负债合计                           5,866,208.80                   5,866,208.80

负债合计                               147,216,104.95                 147,216,104.95

所有者权益:

     股本                              560,327,786.00                 560,327,786.00

     资本公积                           71,028,790.27                  71,028,790.27

     盈余公积                          106,045,817.60                 106,045,817.60

     未分配利润                        147,889,175.57                 147,889,175.57

所有者权益合计                         885,291,569.44                 885,291,569.44

负债和所有者权益总计                 1,032,507,674.39               1,032,507,674.39

调整情况说明
   2017年3月31日,财政部修订了《企业会计准则第22号—金融工具确认和计量》、《企业会计准则第23号—金融资产转
移》、《企业会计准则第24号—套期会计》及《企业会计准则第37号—金融工具列报》,并要求境内上市公司自2019年1月1
日起施行。准则规定,在准则实施日,企业应当按照规定对金融工具进行分类和计量,涉及前期比较财务报表数据与本准则
要求不一致的,无需调整。金融工具原账面价值和在本准则实施日的新账面价值之间的差额,需要调整2019年初留存收益、
其他综合收益及财务报表其他项目金额。本公司于2019年1月1日之后将部分持有的股权投资指定为以公允价值计量且其变动
计入其他综合收益的金融资产,列报为其他权益工具投资。


2、首次执行新金融工具准则、新租赁准则追溯调整前期比较数据的说明

□ 适用 √ 不适用


三、审计报告

第一季度报告是否经过审计
□ 是 √ 否
公司第一季度报告未经审计。




                                                                                                             25
数据加载中...
prevnext
手机查看股票